CBSA urges you to take action now to protect America’s innovation economy! The federal government is considering the use of “march-in rights” as a tool to regulate the price of inventions that were conceived or developed with the help of federal research funding, including Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. This would upend the 43-year-old Bayh-Dole Act, which has supported the creation of thousands of start-ups, millions of jobs, and trillions of dollars in U.S. GDP from inventions at universities. This poses a particular threat to innovation across the life sciences ecosystem.
The comment period on the new Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights closes on February 6, 2024. Please weigh in with input on the federal portal regarding the threat of the proposed…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
